All's well that ends well: Alternative polyadenylation and its implications for stem cell biology

Current Opinion in Cell Biology

Volumn 25, Issue 2, 2013, Pages 222-232

  Mueller, Alisa A ^a   Cheung, Tom H ^a   Rando, Thomas A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CLEAVAGE STIMULATION FACTOR; MESSENGER RNA; MICRORNA; POLYPYRIMIDINE TRACT BINDING PROTEIN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR PAX3;

3' UNTRANSLATED REGION; ADULT STEM CELL; ALLELE; ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELLULAR DISTRIBUTION; CYTOLOGY; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE FUNCTION; LIGAND BINDING; MUSCLE DEVELOPMENT; NEGATIVE FEEDBACK; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; PLURIPOTENT STEM CELL; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROCESSING; RNA METHYLATION; RNA SEQUENCE; SATELLITE CELL; SOMATIC CELL; SPERMATOGENESIS; STEADY STATE; STEM CELL; TRANSCRIPTION REGULATION; ANIMAL; GENETICS; HUMAN; METABOLISM; REVIEW;

ANIMALS; CELL DIFFERENTIATION; HUMANS; POLYADENYLATION; RNA, MESSENGER; STEM CELLS;

MLCS; MLOWN;

EID: 84877929784     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2012.12.008     Document Type: Review

References (86)

1. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, Gerstein M, Snyder M: The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 2008, 320:1344-1349.
2. Ozsolak F, Platt AR, Jones DR, Reifenberger JG, Sass LE, McInerney P, Thompson JF, Bowers J, Jarosz M, Milos PM: Direct RNA sequencing. Nature 2009, 461:814-818.
3. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470.
4. Lutz CS, Moreira A: Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression. Wiley Interdiscipl Rev RNA 2011, 2:22-31.
5. Di Giammartino DC, Nishida K, Manley JL: Mechanisms and consequences of alternative polyadenylation. Mol Cell 2011, 43:853-866.
6. Shi Y: Alternative polyadenylation: new insights from global analyses. RNA 2012, 18:2105-2117.
7. Ozsolak F, Kapranov P, Foissac S, Kim SW, Fishilevich E, Monaghan AP, John B, Milos PM: Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 2010, 143:1018-1029.
8. Tian B, Hu J, Zhang H, Lutz CS: A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res 2005, 33:201-212.
9. Chang ALS, Bitter PH, Qu K, Lin M, Rapicavoli NA, Chang HY: Rejuvenation of gene expression pattern of aged human skin by broadband light treatment: a pilot study. J Investig Dermatol 2013, 133:394-402.
10. Beck AH, Weng Z, Witten DM, Zhu S, Foley JW, Lacroute P, Smith CL, Tibshirani R, van de Rijn M, Sidow A et al.: 30-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS ONE 2010, 5:e8768.
11. Elkon R, Drost J, van Haaften G, Jenal M, Schrier M, Oude Vrielink JA, Agami R: E2F mediates enhanced alternative polyadenylation in proliferation. Genome Biol 2012, 13:R59.
12. Lin Y, Li Z, Ozsolak F, Kim SW, Arango-Argoty G, Liu TT, Tenenbaum SA, Bailey T, Monaghan AP, Milos PM et al.: An indepth map of polyadenylation sites in cancer. Nucleic Acids Res 2012, 40:8460-8471.
13. Haenni S, Ji Z, Hoque M, Rust N, Sharpe H, Eberhard R, Browne C, Hengartner MO, Mellor J, Tian B et al.: Analysis of C. elegans intestinal gene expression and polyadenylation by fluorescence-activated nuclei sorting and 30-end-seq. Nucleic Acids Res 2012, 40:6304-6318.
14. Jan CH, Friedman RC, Ruby JG, Bartel DP: Formation, regulation and evolution of Caenorhabditis elegans 30UTRs. Nature 2011, 469:97-101.
15. Ulitsky I, Shkumatava A, Jan C, Subtelny AO, Koppstein D, Bell G, Sive H, Bartel D: Extensive alternative polyadenylation during zebrafish development. Genome Res 2012, 22:2054-2066.
16. Derti A, Garrett-Engele P, Macisaac KD, Stevens RC, Sriram S, Chen R, Rohl CA, Johnson JM, Babak T: A quantitative atlas of polyadenylation in five mammals. Genome Res 2012, 22:1173-1183.
17. Shepard PJ, Choi E-A, Lu J, Flanagan LA, Hertel KJ, Shi Y: Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. RNA 2011, 17:761-772.
18. Fu Y, Sun Y, Li Y, Li J, Rao X, Chen C, Xu A: Differential genomewide profiling of tandem 30 UTRs among human breast cancer and normal cells by high-throughput sequencing. Genome Res 2011, 21:741-747.
19. Li Y, Sun Y, Fu Y, Li M, Huang G, Zhang C, Liang J, Huang S, Shen G, Yuan S et al.: Dynamic landscape of tandem 30 UTRs during zebrafish development. Genome Res 2012, 22:1899-1906.
20. Mangone M, Manoharan AP, Thierry-Mieg D, Thierry-Mieg J, Han T, Mackowiak SD, Mis E, Zegar C, Gutwein MR, Khivansara V et al.: The landscape of C. elegans 30UTRs. Science 2010, 329:432-435.
21. Li G, Bahn JH, Lee J-H, Peng G, Chen Z, Nelson SF, Xiao X: Identification of allele-specific alternative mRNA processing via transcriptome sequencing. Nucleic Acids Res 2012, 40:e104.
22. Ji Z, Luo W, Li W, Hoque M, Pan Z, Zhao Y, Tian B: Transcriptional activity regulates alternative cleavage and polyadenylation. Mol Syst Biol 2011, 7:534.
23. Katz Y, Wang ET, Airoldi EM, Burge CB: Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 2010, 7:1009-1015.
24. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB: Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
25. Wu X, Liu M, Downie B, Liang C, Ji G, Li QQ, Hunt AG: Genomewide landscape of polyadenylation in Arabidopsis provides evidence for extensive alternative polyadenylation. Proc Natl Acad Sci U S A 2011, 108:12533-12538.
26. Kwan T, Benovoy D, Dias C, Gurd S, Provencher C, Beaulieu P, Hudson TJ, Sladek R, Majewski J: Genome-wide analysis of transcript isoform variation in humans. Nat Genet 2008, 40:225-231.
27. Singh P, Alley TL, Wright SM, Kamdar S, Schott W, Wilpan RY, Mills KD, Graber JH: Global changes in processing of mRNA 30 untranslated regions characterize clinically distinct cancer subtypes. Cancer Res 2009, 69:9422-9430.
28. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB: Proliferating cells express mRNAs with shortened 30 untranslated regions and fewer microRNA target sites. Science 2008, 320:1643-1647.
29. Ji Z, Tian B: Reprogramming of 30 untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS ONE 2009, 4:e8419.
30. Ji Z, Lee JY, Pan Z, Jiang B, Tian B: Progressive lengthening of 30 untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc Natl Acad Sci U S A 2009, 106:7028-7033.
31. Muro EM, Herrington R, Janmohamed S, Frelin C, Andrade- Navarro MA, Iscove NN: Identification of gene 30 ends by automated EST cluster analysis. Proc Natl Acad Sci U S A 2008, 105:20286-20290.
32. Beaudoing E, Gautheret D: Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data. Genome Res 2001, 11:1520-1526.
33. Liu D, Brockman JM, Dass B, Hutchins LN, Singh P, McCarrey JR, MacDonald CC, Graber JH: Systematic variation in mRNA 30-processing signals during mouse spermatogenesis. Nucleic Acids Res 2007, 35:234-246.
34. Zhang H, Hu J, Recce M, Tian B: PolyA_DB: a database for mammalian mRNA polyadenylation. Nucleic Acids Res 2005, 33:D116-D120.
35. Zhang H, Lee JY, Tian B: Biased alternative polyadenylation in human tissues. Genome Biol 2005, 6:R100.
36. Shen Y, Venu RC, Nobuta K, Wu X, Notibala V, Demirci C, Meyers BC, Wang G-L, Ji G, Li QQ: Transcriptome dynamics through alternative polyadenylation in developmental and environmental responses in plants revealed by deep sequencing. Genome Res 2011, 21:1478-1486.
37. Chen M, Manley JL: Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009, 10:741-754.
38. MacDonald CC, McMahon KW: Tissue-specific mechanisms of alternative polyadenylation: testis, brain, and beyond. Wiley Interdiscipl Rev RNA 2010, 1:494-501.
39. Vorlová S, Rocco G, Lefave CV, Jodelka FM, Hess K, Hastings ML, Henke E, Cartegni L: Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation. Mol Cell 2011, 43:927-939.
40. Yao P, Potdar AA, Arif A, Ray PS, Mukhopadhyay R, Willard B, Xu Y, Yan J, Saidel GM, Fox PL: Coding region polyadenylation generates a truncated tRNA synthetase that counters translation repression. Cell 2012, 149:88-100.
41. Lu F, Gladden AB, Diehl JA: An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003, 63:7056-7061.
42. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES: Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 2003, 278:30339-30347.
43. Miura P, Amirouche A, Clow C, Bélanger G, Jasmin BJ: Brainderived neurotrophic factor expression is repressed during myogenic differentiation by miR-206. J Neurochem 2012, 120:230-238.
44. Boutet SC, Cheung TH, Quach NL, Liu L, Prescott SL, Edalati A, Iori K, Rando TA: Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. Cell Stem Cell 2012, 10:327-336.
45. Mayr C, Bartel DP: Widespread shortening of 30UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
46. Muhlrad D, Parker R: Aberrant mRNAs with extended 30 UTRs are substrates for rapid degradation by mRNA surveillance. RNA 1999, 5:1299-1307.
47. Kebaara BW, Atkin AL: Long 30-UTRs target wild-type mRNAs for nonsense-mediated mRNA decay in Saccharomyces cerevisiae. Nucleic Acids Res 2009, 37:2771-2778.
48. Hogg JR, Goff SP: Upf1 senses 30UTR length to potentiate mRNA decay. Cell 2010, 143:379-389.
49. Goodarzi H, Najafabadi HS, Oikonomou P, Greco TM, Fish L, Salavati R, Cristea IM, Tavazoie S: Systematic discovery of structural elements governing stability of mammalian messenger RNAs. Nature 2012, 485:264-268.
50. Andreassi C, Riccio A: To localize or not to localize: mRNA fate is in 30UTR ends. Trends Cell Biol 2009, 19:465-474.
51. Mazumder B, Seshadri V, Fox PL: Translational control by the 30-UTR: the ends specify the means. Trends Biochem Sci 2003, 28:91-98.
52. MacIsaac JL, Bogutz AB, Morrissy AS, Lefebvre L: Tissuespecific alternative polyadenylation at the imprinted gene Mest regulates allelic usage at Copg2. Nucleic Acids Res 2012, 40:1523-1535.
53. Hilgers V, Perry MW, Hendrix D, Stark A, Levine M, Haley B: Neural-specific elongation of 30 UTRs during Drosophila development. Proc Natl Acad Sci U S A 2011, 108:15864-15869.
54. Ohara O, Gahara Y, Teraoka H, Kitamura T: A rat brain-derived neurotrophic factor-encoding gene generates multiple transcripts through alternative use of 50 exons and polyadenylation sites. Gene 1992, 121:383-386.
55. Lau AG, Irier HA, Gu J, Tian D, Ku L, Liu G, Xia M, Fritsch B, Zheng JQ, Dingledine R et al.: Distinct 30UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proc Natl Acad Sci U S A 2010, 107:15945-15950.
56. Dai W, Zhang G, Makeyev EV: RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage. Nucleic Acids Res 2012, 40:787-800.
57. Mansfield KD, Keene JD: Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyadenylation. Nucleic Acids Res 2012, 40:2734-2746.
58. Chennathukuzhi VM, Lefrancois S, Morales CR, Syed V, Hecht NB: Elevated levels of the polyadenylation factor CstF 64 enhance formation of the 1kB Testis brain RNA-binding protein (TBRBP) mRNA in male germ cells. Mol Reprod Dev 2001, 58:460-469.
59. Morales CR, Wu XQ, Hecht NB: The DNA/RNA-binding protein, TB-RBP, moves from the nucleus to the cytoplasm and through intercellular bridges in male germ cells. Dev Biol 1998, 201:113-123.
60. Yao C, Biesinger J, Wan J, Weng L, Xing Y, Xie X, Shi Y: Transcriptome-wide analyses of CstF64-RNA interactions in global regulation of mRNA alternative polyadenylation. Proc Natl Acad Sci U S A 2012, 109:18773-18778.
61. Dass B, Attaya EN, Michelle Wallace A, MacDonald CC: Overexpression of the CstF-64 and CPSF-160 polyadenylation protein messenger RNAs in mouse male germ cells. Biol Reprod 2001, 64:1722-1729.
62. Castelo-Branco P, Furger A, Wollerton M, Smith C, Moreira A, Proudfoot N: Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol Cell Biol 2004, 24:4174-4183.
63. Ashiya M, Grabowski PJ: A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA 1997, 3:996-1015.
64. Lin J-C, Tarn W-Y: RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing. J Cell Biol 2011, 193:509-520.
65. Biressi S, Rando TA: Heterogeneity in the muscle satellite cell population. Semin Cell Dev Biol 2010, 21:845-854.
66. Warren L, Bryder D, Weissman IL, Quake SR: Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR. Proc Natl Acad Sci U S A 2006, 103:17807-17812.
67. Sanchez-Freire V, Ebert AD, Kalisky T, Quake SR, Wu JC: Microfluidic single-cell real-time PCR for comparative analysis of gene expression patterns. Nat Protoc 2012, 7:829-838.
68. Dalerba P, Kalisky T, Sahoo D, Rajendran PS, Rothenberg ME, Leyrat AA, Sim S, Okamoto J, Johnston DM, Qian D et al.: Singlecell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 2011, 29:1120-1127.
69. Ramsköld D, Luo S, Wang Y-C, Li R, Deng Q, Faridani OR, Daniels GA, Khrebtukova I, Loring JF, Laurent LC et al.: Fulllength mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol 2012, 30:777-782.
70. Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N, Wang X, Bodeau J, Tuch BB, Siddiqui A et al.: mRNA-Seq wholetranscriptome analysis of a single cell. Nat Methods 2009, 6:377-382.
71. Ebert MS, Neilson JR, Sharp PA: MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007, 4:721-726.
72. Ebert MS, Sharp PA: MicroRNA sponges: progress and possibilities. RNA 2010, 16:2043-2050.
73. Arvey A, Larsson E, Sander C, Leslie CS, Marks DS: Target mRNA abundance dilutes microRNA and siRNA activity. Mol Syst Biol 2010, 6:363.
74. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP: A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011, 146:353-358.
75. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F et al.: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011, 147:344-357.
76. Sumazin P, Yang X, Chiu H-S, Chung W-J, Iyer A, Llobet-Navas D, Rajbhandari P, Bansal M, Guarnieri P, Silva J et al.: An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 2011, 147:370-381.
77. Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA et al.: In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011, 147:382-395.
78. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I: A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147:358-369.
79. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038.
80. Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi SW, Clark TA, Schweitzer AC, Blume JE, Wang X et al.: HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 2008, 456:464-469.
81. Dittmar KA, Jiang P, Park JW, Amirikian K, Wan J, Shen S, Xing Y, Carstens RP: Genome-wide determination of a broad ESRPregulated posttranscriptional network by high-throughput sequencing. Mol Cell Biol 2012, 32:1468-1482.
82. Jenal M, Elkon R, Loayza-Puch F, van Haaften G, Kühn U, Menzies FM, Vrielink J AFO, Bos AJ, Drost J, Rooijers K et al.: The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 2012, 149:538-553.
83. Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M et al.: Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 2012, 485:201-206.
84. Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR: Comprehensive analysis of mRNA methylation reveals enrichment in 30 UTRs and near stop codons. Cell 2012, 149:1635-1646.
85. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chrétien N, ToméFM, Lafrenière RG, Rommens JM, Uyama E, Nohira O et al.: Short GCG, expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998, 18:164-167.
86. Dalerba P, Cho RW, Clarke MF: Cancer stem cells: models and concepts. Annu Rev Med 2007, 58:267-284.